Werfen S.A. investment portfolio

Osler Diagnostics designs and manufactures the Osler Origin, a portable point‑of‑care diagnostic platform that provides laboratory‑quality test results on‑site. The system is marketed to healthcare settings such as emergency departments, doctors’ offices, retail pharmacies and other locations requiring rapid, on‑the‑spot testing.

Oxford Cancer Analytics develops a machine‑learning platform that analyses the circulating proteome in a minimally invasive blood sample to screen for cancer, targeting high‑risk populations for early, curative detection. The technology is designed to replace invasive tissue biopsies and expensive imaging with a cheaper, earlier diagnostic test.